Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Generation of patient-specific induced pluripotent cells (iPSCs) holds great promise for regenerative medicine. Epstein-Barr virus immortalized lymphoblastoid B-cell lines (LCLs) can be generated from a minimal amount of blood and are banked worldwide as cellular reference material for immunologic or genetic analysis of pedigreed study populations. We report the generation of iPSCs from 2 LCLs (LCL-iPSCs) via a feeder-free episomal method using a cocktail of transcription factors and small molecules. LCL-derived iPSCs exhibited normal karyotype, expressed pluripotency markers, lost oriP/EBNA-1 episomal vectors, generated teratomas, retained donor identity, and differentiated in vitro into hematopoietic, cardiac, neural, and hepatocyte-like lineages. Significantly, although the parental LCLs express viral EBNA-1 and other Epstein-Barr virus latency-related elements for their survival, their presence was not detectable in LCL-iPSCs. Thus, reprogramming LCLs could offer an unlimited source for patient-specific iPSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, even after reprogramming, the EBNA-1 gene from EBV is not detected in the resulting iPSCs [3], which exhibit characteristics similar to iPSCs derived from fibroblasts.”
In the citing paper
“Induced pluripotent stem cells (iPSCs) are useful for studying genetic and rare diseases and can be generated by reprogramming immortalized lymphoblastoid cell lines (LCLs) stored in global repositories with detailed genotype and phenotype data.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Self-citation
Research works printed but not linked: 19
- Yamanaka, 2007, Strategies and new developments in the generation of patient-specific pluripotent stem cells., Cell Stem Cell, 1, 39, 10.1016/j.stem.2007.05.012 · DOI · Paper page
- Amoli, 2008, EBV immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood., Int J Epidemiol, 37, i41, 10.1093/ije/dym285 · DOI · Paper page
- Cobaleda, 2010, Reprogramming of B cells., Methods Mol Biol, 636, 233, 10.1007/978-1-60761-691-7_15 · DOI
- Cobaleda, 2008, Developmental plasticity of lymphocytes., Curr Opin Immunol, 20, 139, 10.1016/j.coi.2008.03.017 · DOI
- Hanna, 2008, Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency., Cell, 133, 250, 10.1016/j.cell.2008.03.028 · DOI · Paper page
- Wada, 2011, Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells., Int Immunol, 23, 65, 10.1093/intimm/dxq458 · DOI
- Chou, 2011, Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures., Cell Res, 21, 518, 10.1038/cr.2011.12 · DOI · Paper page
- Hu, 2011, Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells., Blood, 117, e109, 10.1182/blood-2010-07-298331 · DOI · Paper page
- Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells., Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
- Yu, 2011, Efficient feeder-free episomal reprogramming with small molecules., PLoS ONE, 6, e17557, 10.1371/journal.pone.0017557 · DOI · Paper page
- Gaspar-Maia, 2011, Open chromatin in pluripotency and reprogramming., Nat Rev Mol Cell Biol, 12, 36, 10.1038/nrm3036 · DOI · Paper page
- Sompallae, 2010, Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes., PLoS ONE, 5, e12052, 10.1371/journal.pone.0012052 · doi:10.1371/journal.pone.0012052
- Kuppers, 2009, Clonotypic B cells in classic Hodgkin lymphoma., Blood, 114, 3970, 10.1182/blood-2009-06-229583 · doi:10.1182/blood-2009-06-229583
- van Dongen, 2003, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98–3936., Leukemia, 17, 2257, 10.1038/sj.leu.2403202 · DOI · Paper page
- Leight, 2000, EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus., Rev Med Virol, 10, 83, 10.1002/(SICI)1099-1654(200003/04)10:2<83::AID-RMV262>3.0.CO;2-T · DOI
- Altmann, 2006, Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes., Proc Natl Acad Sci U S A, 103, 14188, 10.1073/pnas.0605985103 · DOI
- Nanbo, 2007, The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells., EMBO J, 26, 4252, 10.1038/sj.emboj.7601853 · DOI · Paper page
- Vereide, 2009, Proof for EBV's sustaining role in Burkitt's lymphomas., Semin Cancer Biol, 19, 389, 10.1016/j.semcancer.2009.07.006 · DOI
- Ryan, 2004, Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma., J Mol Diagn, 6, 378, 10.1016/S1525-1578(10)60535-1 · doi:10.1016/s1525-1578(10)60535-1
Cited by
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Phillips, M. J., Wallace, K. A., Dickerson, S. J., Miller, M. J., Verhoeven, A. D., Martin, J. M., Wright, L. S., Shen, W., Capowski, E. E., Percin, E. F., et al. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9313 · Cited by 201
“Toward ensuring safety, methods now exist to generate integration-free hiPSCs from routine peripheral blood samples.(35) To demonstrate efficacy, significant hurdles must be overcome, including the need to translate our findings in OV cultures to a platform suitable for subretinal transplantation.”
MethodSelf-citationIn Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Niu, N., & Wang, L. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.170 · Cited by 162
Poleganov, M. A., Eminli, S., Beissert, T., Herz, S., Moon, J.-I., Goldmann, J., Beyer, A., Heck, R., Burkhart, I., Barea Roldan, D., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.045 · Cited by 77
Ishii-Teshima, M., Maeda, K., Hanauchi, K., Asechi, E., Setyawan, D., Niki, T., Nakashima, K., Kurita, H., Numano, R., & Shibata, T. (2025) · PLOS One · doi:10.1371/journal.pone.0333491 · Cited by 4
Metadata
- Authors
- Rajesh, D., Dickerson, S. J., Yu, J., Brown, M. E., Thomson, J. A., & Seay, N. J.
- Affiliations
- Cellular Dynamics International Inc, Madison, WI;
- Morgridge Institute for Research, Madison, WI;
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-08-18
- Volume
- 118
- Issue
- 7
- Pages
- 1797-1800
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 63
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. https://app.cochat.ai/papers/10.1182/blood-2011-01-332064
- The paper
- Rajesh, D., Dickerson, S. J., Yu, J., Brown, M. E., Thomson, J. A., & Seay, N. J. (2011). Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. Blood. https://doi.org/10.1182/blood-2011-01-332064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.